Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reply to "An alternative miRISC targets a cancer-associated coding sequence mutation in FOXL2".

Literature DB >> 34396573

Reply to "An alternative miRISC targets a cancer-associated coding sequence mutation in FOXL2".

Reiner A Veitia^1,2,3, Jessica Pilsworth^4,5,6, Anne-Laure Todeschini^1,2, David Huntsman^4,5,6.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2021 PMID： 34396573 PMCID： PMC8365250 DOI： 10.15252/embj.2020107517

Source DB: PubMed Journal: EMBO J ISSN： 0261-4189 Impact factor: 14.012

Keyword Cloud
References

× No keyword cloud information.

8 in total

1. Fluorescent allele-specific PCR (FAS-PCR) improves the reliability of single nucleotide polymorphism screening.

Authors: T D Howard; E R Bleecker; O C Stine
Journal: Biotechniques Date: 1999-03 Impact factor: 1.993

2. Mutation of FOXL2 in granulosa-cell tumors of the ovary.

Authors: Sohrab P Shah; Martin Köbel; Janine Senz; Ryan D Morin; Blaise A Clarke; Kimberly C Wiegand; Gillian Leung; Abdalnasser Zayed; Erika Mehl; Steve E Kalloger; Mark Sun; Ryan Giuliany; Erika Yorida; Steven Jones; Richard Varhol; Kenneth D Swenerton; Dianne Miller; Philip B Clement; Colleen Crane; Jason Madore; Diane Provencher; Peter Leung; Anna DeFazio; Jaswinder Khattra; Gulisa Turashvili; Yongjun Zhao; Thomas Zeng; J N Mark Glover; Barbara Vanderhyden; Chengquan Zhao; Christine A Parkinson; Mercedes Jimenez-Linan; David D L Bowtell; Anne-Marie Mes-Masson; James D Brenton; Samuel A Aparicio; Niki Boyd; Martin Hirst; C Blake Gilks; Marco Marra; David G Huntsman
Journal: N Engl J Med Date: 2009-06-10 Impact factor: 91.245

3. Mutant FOXL2^C134W Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors.

Authors: Stine E Weis-Banke; Mads Lerdrup; Daniela Kleine-Kohlbrecher; Faizaan Mohammad; Simone Sidoli; Ole N Jensen; Toshihiko Yanase; Tomoko Nakamura; Akira Iwase; Anthe Stylianou; Nadeem R Abu-Rustum; Carol Aghajanian; Robert Soslow; Arnaud Da Cruz Paula; Richard P Koche; Britta Weigelt; Jesper Christensen; Kristian Helin; Paul A C Cloos
Journal: Cancer Res Date: 2020-07-08 Impact factor: 12.701

4. The Pathognomonic FOXL2 C134W Mutation Alters DNA-Binding Specificity.

Authors: Annaïck Carles; Genny Trigo-Gonzalez; Qi Cao; S-W Grace Cheng; Michelle Moksa; Misha Bilenky; David G Huntsman; Gregg B Morin; Martin Hirst
Journal: Cancer Res Date: 2020-07-08 Impact factor: 12.701

5. Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor.

Authors: Y Nishi; T Yanase; Y Mu; K Oba; I Ichino; M Saito; M Nomura; C Mukasa; T Okabe; K Goto; R Takayanagi; Y Kashimura; M Haji; H Nawata
Journal: Endocrinology Date: 2001-01 Impact factor: 4.736

Reply to "An alternative miRISC targets a cancer-associated coding sequence mutation in FOXL2".

1. Fluorescent allele-specific PCR (FAS-PCR) improves the reliability of single nucleotide polymorphism screening.

2. Mutation of FOXL2 in granulosa-cell tumors of the ovary.

3. Mutant FOXL2^C134W Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors.

4. The Pathognomonic FOXL2 C134W Mutation Alters DNA-Binding Specificity.

5. Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor.

Review 6. The forkhead factor FOXL2: a novel tumor suppressor?

7. GSK3α, not GSK3β, drives hippocampal NMDAR-dependent LTD via tau-mediated spine anchoring.

8. An alternative miRISC targets a cancer-associated coding sequence mutation in FOXL2.